Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples